Position in NVO
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$323,642
New position
Shares Held
6,751
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#864
of 1,348 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Octavia Wealth Advisors, LLC holds $7,437,513 across 8 Drug Manufacturers - General names. NVO ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,271 | $3,370,435 | |
| 2 | MRK |
Merck & Co., Inc.
|
7,648 | $982,768 | |
| 3 | LLY |
ELI LILLY & Co
|
772 | $925,960 | |
| 4 | PFE |
Pfizer Inc
|
29,381 | $707,494 | |
| 5 | ABBV |
AbbVie Inc.
|
1,934 | $486,671 | |
| 6 | AMGN |
Amgen Inc
|
1,195 | $432,733 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
6,751 | $323,642 | |
| 8 | NVS |
Novartis AG
|
1,326 | $207,810 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $323,642 | 6,751 | Shares | Sole | 2026-07-14 | |
| No filing history on record for this holder in this stock. | ||||||